Sun Pharma concluded the trading session with a closing price of Rs 1784.8, marking a decline of 2.28% today. Sun Pharma is currently trading at Rs 1787.20, with a percentage change of -2.15% today.

Sun Pharmaceutical Industries Ltd. 524715 shares dropped 2.19% to 1,786.05 Indian rupees Friday, on what proved to be an all-around dismal trading session for the stock market, with the BSE SENSEX ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.91% to 1,837.30 Indian rupees Wednesday, on what proved to be an all-around grim trading session for the stock market, with the ...

Sun Pharmaceuticals is the largest pharmaceutical company from India and the fifth largest specialty generic company in the world. It has capabilities across dosage forms like injectables, sprays, ...

Dazostinag sodium is under clinical development by Takeda Pharmaceutical and currently in Phase II for Hypopharyngeal Cancer. According to GlobalData, Phase II drugs for Hypopharyngeal Cancer does not ...

Earth will reach perihelion at 09:00 Universal Time on Saturday, January 4, 2025, the closest point to the sun in its annual, slightly elliptical orbit. The word comes from the Greek words peri ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...

Novo Nordisk, for its part, is expected to jump from 10th place to sixth this year, according to Evaluate Pharma’s consensus forecasts. Nevertheless, it’s Roche that’s been tipped to stand ...

Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda ...